SLDB Solid Biosciences Inc.
Healthcare$6.62+1.85%ClosedMarket Cap: $515.8M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$16.67
Target (Median)
$16.00
Target Range
$16.00 - $18.00
Upside from current price: 151.8%
Rating Distribution
4 Strong Buy10 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-18 | Wedbush | maintain | Outperform | Outperform |
| 2026-05-13 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-03-25 | JP Morgan | maintain | Overweight | Overweight |
| 2026-03-23 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-20 | Chardan Capital | maintain | Buy | Buy |
| 2026-03-20 | Needham | maintain | Buy | Buy |
| 2026-03-12 | Wedbush | maintain | Outperform | Outperform |
| 2026-02-09 | Needham | maintain | Buy | Buy |
| 2025-11-05 | Citigroup | maintain | Buy | Buy |
| 2025-11-05 | JP Morgan | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.90 | $14.8M | 10 |
| Sun Dec 31 | $-1.24 | $127.6M | 6 |
| Mon Dec 31 | $0.08 | $279.6M | 4 |
| Tue Dec 31 | $1.14 | $456.3M | 2 |